AU2005261699B2 - Novel sequence for improving expression of nucleic acid - Google Patents

Novel sequence for improving expression of nucleic acid Download PDF

Info

Publication number
AU2005261699B2
AU2005261699B2 AU2005261699A AU2005261699A AU2005261699B2 AU 2005261699 B2 AU2005261699 B2 AU 2005261699B2 AU 2005261699 A AU2005261699 A AU 2005261699A AU 2005261699 A AU2005261699 A AU 2005261699A AU 2005261699 B2 AU2005261699 B2 AU 2005261699B2
Authority
AU
Australia
Prior art keywords
repressor
nucleic acid
sequences
sequence
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005261699A
Other languages
English (en)
Other versions
AU2005261699A1 (en
Inventor
Theodorus Hendrikus Jacobus Kwaks
Arie Pieter Otte
Richard George Antonius Bernardus Sewalt
Henricus Johannes Maria Van Blokland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chromagenics BV
Original Assignee
Chromagenics BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005261699(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chromagenics BV filed Critical Chromagenics BV
Publication of AU2005261699A1 publication Critical patent/AU2005261699A1/en
Application granted granted Critical
Publication of AU2005261699B2 publication Critical patent/AU2005261699B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2005261699A 2004-07-08 2005-07-07 Novel sequence for improving expression of nucleic acid Ceased AU2005261699B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58700704P 2004-07-08 2004-07-08
EPPCT/EP2004/051405 2004-07-08
US60/587,007 2004-07-08
EP2004051405 2004-07-08
PCT/EP2005/053251 WO2006005718A2 (en) 2004-07-08 2005-07-07 Novel sequence for improving expression of nucleic acid

Publications (2)

Publication Number Publication Date
AU2005261699A1 AU2005261699A1 (en) 2006-01-19
AU2005261699B2 true AU2005261699B2 (en) 2009-07-23

Family

ID=34971366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005261699A Ceased AU2005261699B2 (en) 2004-07-08 2005-07-07 Novel sequence for improving expression of nucleic acid

Country Status (19)

Country Link
US (1) US7825232B2 (enExample)
JP (1) JP4805262B2 (enExample)
KR (1) KR101188013B1 (enExample)
CN (1) CN1981057B (enExample)
AT (1) ATE378426T1 (enExample)
AU (1) AU2005261699B2 (enExample)
BR (1) BRPI0512798A (enExample)
CA (1) CA2573022C (enExample)
DE (1) DE602005003369T2 (enExample)
DK (1) DK1763586T3 (enExample)
EA (1) EA011747B1 (enExample)
ES (1) ES2296201T3 (enExample)
IL (1) IL180531A (enExample)
MX (1) MXPA06014553A (enExample)
NO (1) NO341862B1 (enExample)
NZ (1) NZ551510A (enExample)
PT (1) PT1763586E (enExample)
WO (1) WO2006005718A2 (enExample)
ZA (1) ZA200610470B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1572994T3 (da) * 2002-12-20 2007-05-29 Chromagenics Bv Midler og fremgangsmåder til fremstilling af en protein gennem chromatinåbnere, som kan göre chromatin mere tilgængeligt for transkriptionsfaktorer
BRPI0517380A (pt) * 2004-11-08 2008-10-07 Chromagenics Bv molécula de dna, cassete de expressão, célula hospedeira, e, métodos para gerar uma célula hospedeira que expressa um polipeptìdeo de interesse e para produzir um polipeptìdeo de interesse
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
NZ553700A (en) 2004-11-08 2010-09-30 Chromagenics Bv Selection of host cells expressing protein at high levels using a selectable marker with a non-optimal start codon
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
CN102459607B (zh) * 2009-06-15 2014-08-06 萨拉基尼克有限公司 新的严格的可选择的标志物
BR112012031694A2 (pt) 2010-06-15 2016-02-16 Cellagenics B V fragmento de ácido nucleíco, construto de ácido nucleíco, vetor de expressão, célula hospedeira, método de geração de uma célula hospedeira para a expressão de um produto gênico de interesse, e, método de expresão de um produto de gene de interesse
CN103180443B (zh) 2010-09-01 2016-01-13 萨拉基尼克有限公司 用于增强基因表达的来自核糖体蛋白启动子的核酸片段
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60237048D1 (de) * 2001-07-04 2010-08-26 Chromagenics Bv DNS-Sequenzen mit Anti-Repressor-Aktivität
CA2489475C (en) 2002-06-14 2011-03-29 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
DK1572994T3 (da) * 2002-12-20 2007-05-29 Chromagenics Bv Midler og fremgangsmåder til fremstilling af en protein gennem chromatinåbnere, som kan göre chromatin mere tilgængeligt for transkriptionsfaktorer

Also Published As

Publication number Publication date
BRPI0512798A (pt) 2008-04-08
KR101188013B1 (ko) 2012-10-08
DK1763586T3 (da) 2008-03-17
WO2006005718A2 (en) 2006-01-19
IL180531A (en) 2011-04-28
HK1097004A1 (en) 2007-06-15
ZA200610470B (en) 2008-09-25
MXPA06014553A (es) 2007-03-12
CA2573022A1 (en) 2006-01-19
CN1981057B (zh) 2012-07-04
CA2573022C (en) 2012-03-06
NZ551510A (en) 2009-10-30
PT1763586E (pt) 2008-02-25
JP4805262B2 (ja) 2011-11-02
NO20070757L (no) 2007-02-08
JP2008505626A (ja) 2008-02-28
AU2005261699A1 (en) 2006-01-19
ATE378426T1 (de) 2007-11-15
EA011747B1 (ru) 2009-06-30
ES2296201T3 (es) 2008-04-16
EA200700233A1 (ru) 2007-06-29
WO2006005718A3 (en) 2006-08-17
US7825232B2 (en) 2010-11-02
NO341862B1 (no) 2018-02-12
DE602005003369T2 (de) 2009-03-05
CN1981057A (zh) 2007-06-13
US20070212755A1 (en) 2007-09-13
KR20070042122A (ko) 2007-04-20
IL180531A0 (en) 2007-06-03
DE602005003369D1 (de) 2007-12-27

Similar Documents

Publication Publication Date Title
US8771984B2 (en) Selection of host cells expressing protein at high levels
AU2005300503B2 (en) Selection of host cells expressing protein at high levels
US9228004B2 (en) Selection of host cells expressing protein at high levels
NO341862B1 (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
JP4307079B2 (ja) マトリックス付着領域およびその使用方法
AU2003238719B2 (en) A method for simultaneous production of multiple proteins, vectors and cells for use therein
EP1572994B1 (en) Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US7968700B2 (en) Expression augmenting DNA fragments, use thereof, and methods for finding thereof
WO2005059149A2 (en) Improved protein production
WO2018150345A1 (en) An expression vector
EP1763586B1 (en) Novel sequence for improving expression of nucleic acid
HK1097004B (en) Novel sequence for improving expression of nucleic acid
HK1101264B (en) Selection of host cells expressing protein at high levels
ES2372703T3 (es) Fragmentos de adn que aumentan la expresión, uso de los mismos y procedimientos para encontrarlos.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired